[1]翁志成,杨维竹,江娜,等.CT引导下125I放射性粒子植入治疗肝癌门静脉癌栓的疗效评价[J].介入放射学杂志,2010,(07):535.
 WENG Zhicheng,YANG Weizhu,JIANG Na,et al.Evaluation of CT-guided125I seed implantation combined with transcatheter arterial chemoem-bolization in treating portal vein tumor thrombus associated with hepatocellular carcinoma[J].journal interventional radiology,2010,(07):535.
点击复制

CT引导下 125 I放射性粒子植入治疗肝癌门静脉癌栓的疗效评价()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2010年07期
页码:
535
栏目:
肿瘤介入
出版日期:
2010-07-15

文章信息/Info

Title:
Evaluation of CT-guided 125 I seed implantation combined with transcatheter arterial chemoem-bolization in treating portal vein tumor thrombus associated with hepatocellular carcinoma
作者:
翁志成杨维竹江娜
350001福州福建医科大学附属协和医院介入科
Author(s):
WENG Zhi-chengYANG Wei-zhuJIANG Na ZHEN Qu-bingHUANG Jing-yaoHUANG NingSHEN QuanWU Zheng-zhongXIE Hang.
the Affiliated Union Hospital,Fujian Medical University,Fuzhou350001,China
关键词:
肝细胞癌门静脉癌栓碘放射性核素疗效
分类号:
R735.7
文献标志码:
A
摘要:
目的探讨CT引导下 125 I放射性粒子植入联合肝动脉化疗栓塞术(TACE)治疗肝癌合并门静脉癌栓(PVTT)的疗效。方法回顾性分析原发性肝癌合并PVTT患者58例,A组(26例)行TACE结合CT引导下 125 I放射性粒子植入局部放射治疗;B组(32例)单纯行TACE。对比两组疗效。结果A组1、2年生存率分别为42.3%、23.0%,平均生存期15.5个月,完全缓解(CR)3例,部分缓解(PR)9例,总有效率(CR+PR)为46.2%(12/26)。B组1、2年生存率分别为21.9%、6.3%,平均生存期7.5个月CR2例,PR6例,CR+PR为25.0%(8/32)。A组的生存率及总有效率显著高于B组(P<0.05)。结论TACE联合CT引导下 125 I放射性粒子植入治疗肝癌门脉癌栓能明显提高其疗效,并具有创伤少,并发症少等优点。

参考文献/References:

[1]Minagawa M,Makuuchi M,Takayama T,et al.Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus[J].Ann Surg,2001,233:379-384.
[2]Sorensen HT,MellemKjaer L,Olsen JH,et al.Prognosis of cancers associated with venous thromboem bolism[J].N Engl J Med,2003,343:
[3]Takizawa D,Kakizaki S,Sohara N,et al.Hepatocellular carcinoma with portal vein tumor thrombosis:clinical characteristics.prognosis,and patient survival analysis[J].Dig Dis Sci,2007,52:3290-3295.
[4]徐爱民,程红岩,陈栋,等.放射介入栓塞化疗对肝癌合并门静脉癌栓治疗的疗效观察[J].中国实用外科杂志,2002,22:530-532.
[5]程树群,吴孟超,陈汉,等.外科综合治疗对肝细胞癌合并门静脉癌栓的疗效观察[J].中华肝胆外科杂志,2004,10:662-664.
[6]Minagawa M,Makuuchi M,Takayana T,et al.Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus[J].Ann Surg,2001,233:379-384.
[7]Izaki K,Sugimoto K,Sugimura K,et al.Transcatheter arterial embolization for advanced tumor thrombus with marked arterioportal or arteriovenous shunt complicating hepatocellular carcinoma [J].Radiat Med,2004,22:155-162.
[8]Yamada K,Lzaki K,Sugimoto K,et al.Prospective trial of combined transcatheter arterial chemoembolization and threedimensional conformal radiotherapy for portal vein tumor thrombus in patientswith unresectable hepatocellular carcinoma [J].Int J Radiat Oncol BiolPhys,2004,57:113-119.
[9]Qin LX,Tang ZY.The prognostic molecular markers in hepatocellular carcinoma [J].World J Gastroenterol,2002,8:385-392.
[10]Fukuda S,Okuda K,Imamura M,et al.Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus:report of19cases[J].Surgery,2002,131:300-310.
[11]吴汉平,冯敢生.肝癌介入治疗的现状与展望[J].临床放射学杂志,2005,24:273-276.
[12]刘清欣,颜志平,李锐,等. 125 I粒子条联合门静脉支架及化疗栓塞治疗原发性肝癌合并门静脉癌栓[J].介入放射学杂志,2009,18:593-595.
[13]程树群,吴孟超,陈汉,等.癌栓分型对肝细胞性肝癌合并门静脉癌栓治疗及预后的指导意义[J].中华医学杂志,2004,84:3-5.
[14]Inoue Y,Hasegawa K,Ishizawa T,et al.Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma [J].Surgery,2009,145:9-19.
[15]张辉,莫日根.TACE联合CT导向下 125 I放射性粒子植入治疗肝癌[J].介入放射学杂志,2009,18:702-704.
[16]邵成伟,田建明,左长京,等.CT引导下 125 I放射性粒子植入治疗胰腺癌的疗效评价[J].介入放射学杂志,2007,12:825-827.

相似文献/References:

[1]郭丽萍,张晓玲,王莉娜.经导管肝动脉化疗栓塞联合高强度聚焦超声治疗原发性肝癌的护理[J].介入放射学杂志,2010,(04):328.
 GUO Liping,ZHANG Xiaoling,WANG Lina.The nursing care for patients of hepatocellular carcinoma treated with transcatheter hepatic arterial chemoembolization and high intensive focus ultrasound[J].journal interventional radiology,2010,(07):328.
[2]沈海洋,杨光,刘瑞宝,等.肝右叶前、后段原发性肝癌动脉化疗栓塞术后近期疗效比较[J].介入放射学杂志,2010,(05):382.
 SHEN Haiyang,YANG Guang,LIU Ruibao,et al.Short-term effects of TACE for primary hepatocellular carcinoma of the right hepatic lobe:a comparison between the lesions in anterior segments and the lesions in posterior segments[J].journal interventional radiology,2010,(07):382.
[3]池嘉昌,沈加林,许建荣,等.全肝CT灌注成像在原发性肝癌TACE术后局部病灶活性评估中的临床应用[J].介入放射学杂志,2010,(07):540.
 CHI Jiachang,SHEN Jialin,XU Jianrong,et al.Clinical application of whole-liver perfusion-enhanced CT imaging in evaluating the activity of residual hepatocellular carcinoma after TACE[J].journal interventional radiology,2010,(07):540.
[4]王悍 王精兵 张贵祥 王麟川.肝细胞癌动脉化疗栓塞术后并发脑梗死一例[J].介入放射学杂志,2005,(04):442.
 WANG Han WANG Jing-bing ZHANG Gui-xiang WANG Lin-chuan.Cerebral infarction aften transaterial shemoembolization for hepatocellular carcinoma a cage report[J].journal interventional radiology,2005,(07):442.
[5]张绪敬,程佩芳,董光,等.原发性肝癌经导管化疗、栓塞前后血中凝血酶原变化的研究[J].介入放射学杂志,1992,(01):33.
[6]欧阳墉,马和平,张学军,等.肝细胞癌的鉴别诊断——附10例分析[J].介入放射学杂志,1996,(01):40.
[7]龚高全,王小林,王建华,等.肝癌门静脉支架植入术对门静脉压力的影响[J].介入放射学杂志,2007,(03):159.
 GONG Gao-quan,WANG Xiao-lin,WANG Jian-hua,et al.The portal venous pressure change due to metallic stents implanted into portal veins in HCC patients[J].journal interventional radiology,2007,(07):159.
[8]周斌,李征然,钱结胜,等.原发性肝癌肝移植后肿瘤复发的化疗栓塞治疗[J].介入放射学杂志,2009,(03):185.
 ZHOU Bin,LI Zhengran,QIAN Jiesheng,et al.Chemoembolization for recurrent hepatocellular carcinoma after liver transplantation[J].journal interventional radiology,2009,(07):185.
[9]李强,曾从俊,王莺.化疗栓塞联合质子放射治疗肝癌合并门脉主干癌栓的临床应用[J].介入放射学杂志,2009,(04):278.
 LI Qiang,ZENG Congjun,WANG Ying.Interventional chemoembolization combined with proton radiotherapy for the treatment of hepatocellular carcinoma accompanied with portal cancerous thrombus[J].journal interventional radiology,2009,(07):278.
[10]黄渊全,贾中芝,冯耀良,等.CT灌注成像在肝癌TACE术后疗效评价中的应用价值[J].介入放射学杂志,2009,(06):437.
 HUANG Yuan-quan,JIA Zhong-zhi,FENG Yao-liang,et al.Clinical application of CT perfusion imaging in estimating the efficacy of transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma[J].journal interventional radiology,2009,(07):437.

备注/Memo

备注/Memo:
收稿日期:2009-12-17
更新日期/Last Update: 2010-07-15